Endothelial dysfunction in pre-eclampsia.
Journal Title: Pharmacological Reports - Year 2006, Vol 58, Issue 0
Abstract
The repeated demonstration of biomarkers of endothelial cell and leukocyte activation has suggested that the maternal syndrome of pre-eclampsia arises from a generalised maternal inflammatory systemic response incorporating a substantive component of endothelial cell dysfunction. Reports of reduced endothelium dependent dilatation in isolated resistance arteries and from non invasive methods in vivo indicate a major contribution to the systemic vasoconstriction, characteristic of the syndrome. The recent discovery of raised concentrations of soluble fms-like tyrosine kinase1(sFlt1) and the soluble transforming growth factor beta (TGF-beta) coreceptor (sEng) sEng which indirectly may compromise endothelial function, adds to the growing list of potential origins of endothelial disturbance. Most are proposed to originate from placental underperfusion and associated placental oxidative stress, although it is clear that not all women with pre-eclampsia have reduced utero-placental blood flow, and other precipitating factors, including dyslipidaemia and hyperglycaemia are likely to contribute. Endothelial dysfunction, unlike pre-eclampsia, does not resolve post-partum, and persistence of the defect may underpin the increased risk of cardiovascular disease in later life.
Authors and Affiliations
Lucilla Poston
Keywords
Related Articles
- EP ID EP102030
- DOI -
- Views 102
- Downloads 0
Anti-apoptotic effect of phloretin on cisplatin-induced apoptosis in HEI-OC1 auditory cells.
Cisplatin is a highly effective chemotherapeutic agent, but it has significant ototoxic side effects. Apoptosis is an important mechanism of cochlear hair cell loss following exposure to cisplatin. The present study exam...
Differential response of human healthy lymphoblastoid and CCRF-SB leukemia cells to sulforaphane and its two analogues: 2-oxohexyl isothiocyanate and alyssin.
The chemopreventive effect of sulforaphane and two of its analogues on human B-lymphocytes derived cells was evaluated in this study. Two cell lines used in the experiments were: human lymphoblastoid cells and human B-le...
Oleanolic acid derivative methyl 3,11-dioxoolean-12-en-28-olate targets multidrug resistance related to ABCB1.
Multidrug resistance (MDR) in leukemia patients is a great incentive to the development of new drugs. In a search for potential multidrug resistance modulators we tested a group of oleanolic acid (OA) analogues modified...
Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo.
Background: Levosimendan and its long-lived metabolite OR-1896 produce vasodilation in different types of vessels by activating ATP-sensitive (KATP) and other potassium channels. Methods: In the present study we applied...
New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation.
Background: Our previous studies in a group of arylpiperazine derivatives of 1,3-dimethyl-3,7-dihydro-purine-2,6-diones, aimed at chemical diversification of the purine-2,6-dione by introduction of hydrophobic substituen...